Sage Therapeutics Overview

Sage Therapeutics Selling, General & Admin

Selling, General & Admin expenses for SAGE.

Quarterly SG&A Expenses

$62.00M

↑ 10.74% YoY

As of Jun 30, 2025

Annual SG&A Expenses (TTM)

$227.45M

↓ 5.7% YoY

Trailing 12 months ending Jun 30, 2025

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin